Correlation Between Visa and OliX PharmaceuticalsI
Can any of the company-specific risk be diversified away by investing in both Visa and OliX PharmaceuticalsI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and OliX PharmaceuticalsI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and OliX PharmaceuticalsInc, you can compare the effects of market volatilities on Visa and OliX PharmaceuticalsI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of OliX PharmaceuticalsI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and OliX PharmaceuticalsI.
Diversification Opportunities for Visa and OliX PharmaceuticalsI
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Visa and OliX is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and OliX PharmaceuticalsInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OliX PharmaceuticalsInc and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with OliX PharmaceuticalsI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OliX PharmaceuticalsInc has no effect on the direction of Visa i.e., Visa and OliX PharmaceuticalsI go up and down completely randomly.
Pair Corralation between Visa and OliX PharmaceuticalsI
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.15 times more return on investment than OliX PharmaceuticalsI. However, Visa Class A is 6.74 times less risky than OliX PharmaceuticalsI. It trades about 0.13 of its potential returns per unit of risk. OliX PharmaceuticalsInc is currently generating about -0.09 per unit of risk. If you would invest 30,990 in Visa Class A on September 22, 2024 and sell it today you would earn a total of 781.00 from holding Visa Class A or generate 2.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.45% |
Values | Daily Returns |
Visa Class A vs. OliX PharmaceuticalsInc
Performance |
Timeline |
Visa Class A |
OliX PharmaceuticalsInc |
Visa and OliX PharmaceuticalsI Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Visa and OliX PharmaceuticalsI
The main advantage of trading using opposite Visa and OliX PharmaceuticalsI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, OliX PharmaceuticalsI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OliX PharmaceuticalsI will offset losses from the drop in OliX PharmaceuticalsI's long position.The idea behind Visa Class A and OliX PharmaceuticalsInc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.OliX PharmaceuticalsI vs. ABL Bio | OliX PharmaceuticalsI vs. ALTEOGEN | OliX PharmaceuticalsI vs. Kmw Inc | OliX PharmaceuticalsI vs. Celltrion Pharm |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |